Lynn Sartori joined Moderna in October 2021 as Medical Director Australia - Asia Pacific and is responsible for overseeing the development and implementation of medical strategies for Moderna vaccines and therapeutics in Australia and NZ. Lynn’s career spans roles in the UK, France and Australia where she has led medical, regulatory and quality teams, including a brief period in local government as the Director of Cancer Screening for the Cancer Institute NSW. Lynn has extensive pharmaceutical experience, having worked in immunology, neurology, oncology and rare diseases, with her most recent role prior to her move to Moderna as the Australia, NZ and Southern Cluster lead at Alexion Pharmaceuticals.

Medical Director, Australia & NZ - Asia Pacific, Moderna

LYNN SARTORI

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by: